technology and platforms

our projects

The project portfolio of Xlife Sciences AG is based on four pillars: technology platforms, biotech and therapies, medical technology and artificial intelligence. Our co-investors benefit from our unique selling proposition. In addition, our broad project portfolio offers adequate risk diversification.

Inventum Genetics GmbH

Technology Platforms

Inventum Genetics GmbH was incorporated in 2019 in Mainz, Germany. The company is dedicated to identify new therapeutic approaches and biomarker for common diseases based on human genetic data.

Learn more

VERAXA Biotech GmbH

Technology Platforms

In December 2020, Veraxa Biotech AG, Zurich, Switzerland, was incorporated toacquire Araxa Biosciences GmbH, Heidelberg, Germany, and Velabs TherapeuticsGmbH, Heidelberg, Germany. Araxa Biosciences GmbH was incorporated in January2019 and Velabs Therapeutics GmbH in 2017, both spin-off companies from theEuropean Molecular Biology Laboratory (EMBL) in Heidelberg and its technology transfer arm EMBLEM Technology Transfer GmbH. In 2021, Araxa Biosciences GmbH and Velabs Therapeutics GmbH merged to become Veraxa Biotech GmbH, which isfully owned by the Swiss entity Veraxa Biotech AG. Veraxa Biotech AG operates through Veraxa Biotech GmbH.

Learn more

palleos healthcare GmbH

Technology Platforms

The palleos healthcare GmbH was incorporated in 2013 and is a full service clinical research organization ("CRO")based in Wiesbaden, Germany.

Learn more

Sign up for our media releases

We regularly report on the business development of Xlife Sciences AG and our project companies.